Name : Dr. Kapil Dev Designation : Scientist Address : CSIR-CIMAP, Near Kukrail Picnic Spot, Lucknow-226015, India E. mail : kapildev[at]cimap[dot]res[dot]in Contact No : 9450816954 Fax : 538 Area of Specialization Natural Product Chemistry, Medicinal Chemistry, For more information please visit: https://sites.google.com/view/kapilslab/home Education B.Sc. Chemistry, Physics, Mathematics M.Sc. Pharmaceutical Chemistry Ph.D. Chemical Sciences Academic/Research Experience CSIR-Central Drug Research Institute, Lucknow, India , - Project Assistant-II (March 2010- July 2012 ) CSIR-Central Drug Research Institute, Lucknow, India , - CSIR-Junior Research Fellow (July 2012- July 2014 ) CSIR-Central Drug Research Institute, Lucknow, India, - CSIR-Senior Research Fellow (July 2014- January 2017 ) Jubilant Chemsys Pvt. Ltd., Noida, India, - Research Scientist-II (March 2017- February 2019 ) Yunnan University, Kunming, China, - Postdoctoral Research Fellow (March 2019- November 2019 ) CSIR-CIMAP, Lucknow, - Scientist (November 2019- till date ) Honours and Awards Best Poster Award,by HNBGU, Dehradun, India in 2012 Technology Award,by CSIR-CDRI, Lucknow in 2019 Incentive Award,by CSIR-CDRI, Lucknow in 2020 Publication Singh, A.; Singh, P.; Kumar, B.; Kumar, S.; Dev, K.; Maurya, R.,. Detection of flavonoids from Spinacia oleracea leaves using HPLC-ESI-QTOF-MS/MS and UPLCQqQLIT-MS/MS techniques. Natural Products Research 2018 Choudhary, D.; Kothari, P.; Tripathi, A. K.; Singh, S.; Adhikary, S.; Ahmad, N.; Kumar, S.; Dev, K.; Mishra, V. K.; Shukla, S.; Maurya, R.; Mishra, P. R.; Trivedi, R.,. Spinacia oleracea extract attenuates disease progression and sub-chondral bone changes in monosodium iodoacetate induced osteoarthritis in rats. BMC Complementary and Alternative Medicine 2018 Maurya S. W.; Dev, K.; Prakash, R.; John, A. A.; Siddiqui, I. R.; Singh, D.; Maurya, R., . Design and synthesis of indolyl chalcone analogues and evaluation of their osteogenic activity. Journal of Pharmacology and Pharmaceutical Research 2018 Gautam Brahmachari, Kapil Dev; E. Ramakrishna; Rakesh Maurya;. Glucose Transporter 4 (GLUT4) Translocation Activators from Nature. Discovery and Development of Anti-Diabetic Agents from Natural Products: Natural Product Drug Discovery, Elsevier, ISBN: 978-0-128-09692-5, 2016, Chapter 4, pp 113-145 2017 Prof. Gautam Brahmachari; Kapil Dev; Rakesh Maurya;. Marine-Derived Anti-Alzheimer’s Agents of Promise. Neuroprotective Natural Products: Clinical Aspects and Mode of Action Wiley-VCH, ISBN: 978-3-527-34186-3, 2017, Chapter 7, pp 153-184 2017 Dev, K.; Srivastava, S.; Bisht, R. . Chemical and Pharmacological Profile of Psidium guajava: A Mini Review. Indian Forester Journal 2022 Pandey, J.; Dev, K.; Chattopadhyay, S.; Kadan, S.; Sharma, T.; Sanyal, S.; Siddiqi, M. I.; Zaid, I.; & Tamrakar, A.. ß-Sitosterol-D-Glucopyranoside Mimics Estrogenic Properties and Stimulates Glucose Utilization in Skeletal Muscle Cells. Molecules 2021 Trivedi, R.; Adhikary, S.; Kothari, P.; Ahmad, N.; Mittapelly, N.; Pandey, G.; Shukla, M.; Kumar, S.; Dev, K.; Choudhary, D.; Maurya, R.; Lal, J.; Mishra, P. R.,. Self-emulsifying formulation of Spinacia oleracea reduces the dose and escalates bioavailability of bioactive compounds to accelerate fracture repair in rats. Clinical Phytoscience 2020 Dev, K.; Ramakrishna, E.; Kothari, P.; Tripathi, A. K.; Trivedi, R. and Maurya, R.. Phytochemical investigation of Kigelia pinnata leaves and identification of osteogenic agents. Medicinal Chemistry Research, 2017, 26, 940-940 2017 Singh, K. B.; Dixit, M.; Dev, K.; Rakesh Maurya; and Divya Singh.. Formononetin, a methoxy isoflavone, enhances bone regeneration in a mouse model of cortical bone defect.. British Journal of Nutrition, 117, 1511-1522 2017 Dev, K.; Ramakrishna, E.; Maurya, S. W.; Siddiqui, I. R.; Kant, R. and Maurya, R.. Ugi three-component reaction of alcohols, amines and isocyanides: A new approach to the synthesis of cyclic amidines. Tetrahedron Letters , 58, 1202-1206, 2017 Dev, K.; Ramakrishna, E.; Maurya, S. W.; Siddiqui, I. R. and Maurya, R.. Hypervalent iodine (III)-mediated oxidation of aryl sulfonylhydrazones: A facile synthesis of N-aroyl-N'-acyl arylsulfonylhydrazides. Tetrahedron Letters, 58, 570-573, 2017 Patents File No Title Inventors Patent No. Abstract 10265297 Formulation for the prevention and treatment of bone related disorders Ritu Trivedi; Prabhat R. Mishra; Sulekha Adhikari; Naseer Ahmad; Dharmendra Chaudhary; Naresh Mittapally; Sudhir Kumar; Kapil Dev; Rakesh Maurya United States/10265297/23-04-2019 00:00:00 The present invention relates to a formulation of Spinacea oleracea useful for the prevention or treatment of osteo-health related disorders. The present invention relates to the field of pharmaceutical formulation that provides extract, fractions, pure compound isolated from natural sources and formulation thereof useful for the prevention and treatment of various medical indications. Further, this invention relates to conditions associated with estrogen dependent or independent diseases (primary/secondary osteoporosis) or syndromes or disorders preferably relating to cartilage such as osteoarthritis caused in humans and animals. Furthermore, this invention relates to achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly, the present invention relates to the processes for the preparation of biologically active extracts, from Spinacea oleracea from the family Amaranthaceae their pharmaceutically acceptable excipients and compositions of the principal aspect of the present invention. 20180000776 Pharmaceutical composition for the prevention and/or treatment of bone related disorders Ritu Trivedi; Prabhat R. Mishra; Sulekha Adhikari; Naseer Ahmad; Dharmendra Chaudhary; Naresh Mittapally; Sudhir Kumar; Kapil Dev; Rakesh Maurya India/20180000776 /08-05-2023 00:00:00 The present invention relates to a formulation of Spinacea oleracea useful for the prevention or treatment of osteo-health related disorders. The present invention relates to the field of pharmaceutical formulation that provides extract, fractions, pure compound isolated from natural sources and formulation thereof useful for the prevention and treatment of various medical indications. Further, this invention relates to conditions associated with estrogen dependent or independent diseases (primary/secondary osteoporosis) or syndromes or disorders preferably relating to cartilage such as osteoarthritis caused in humans and animals. Furthermore, this invention relates to achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly, the present invention relates to the processes for the preparation of biologically active extracts, from Spinacea oleracea from the family Amaranthaceae their pharmaceutically acceptable excipients and compositions of the principal aspect of the present invention.